-

BrainCheck Achieves HITRUST i1 Certification, Demonstrating Commitment to Cybersecurity and Information Protection

HITRUST Certification validates that BrainCheck is meeting rigorous cybersecurity and data protection standards through independent assessment and assurance.

AUSTIN, Texas--(BUSINESS WIRE)--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, today announced that its BrainCheck Platform, hosted on Amazon Web Services (AWS), has earned HITRUST CSF Certified status for cybersecurity and information protection.

“Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.” – Bassel Samman, BrainCheck CTO

Share

The HITRUST Certification demonstrates that the BrainCheck Platform has met requirements defined by leading cybersecurity and regulatory frameworks, confirming that strong controls are in place to protect sensitive data and manage risk effectively.

Built on the HITRUST Assurance Program, this achievement reflects independent third-party testing, centralized quality assurance, and certification backed by HITRUST’s Cyber Threat-Adaptive engine. These elements ensure continuous alignment with the latest threat intelligence and evolving standards across NIST, ISO, and OWASP.

“As cybersecurity expectations rise, our stakeholders expect credible, validated assurance,” said Bassel Samman, CTO at BrainCheck. “Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.”

“Earning HITRUST Certification demonstrates BrainCheck’s commitment to managing information risk and protecting sensitive data through a rigorous, proven assurance process,” said Gregory Webb, CEO of HITRUST. “This achievement reflects the organization’s proactive approach to cybersecurity and trust.”

To learn more, visit www.braincheck.com.

About BrainCheck

BrainCheck is an FDA Class II–cleared digital platform for cognitive assessment and care, used by over 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic. Clinicians use BrainCheck’s validated screeners and care planning tools to create tailored protocols, completing more than 400,000 cognitive assessments to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

BrainCheck


Release Versions

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

Social Media Profiles
More News From BrainCheck

Peer-Reviewed Study Design Paper Published for PREDICTOM Alzheimer's Screening Initiative Featuring BrainCheck

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a cognitive workflow platform, today highlighted the publication of a peer-reviewed study design paper for PREDICTOM — the large-scale European Alzheimer's early detection initiative in which BrainCheck Assess is serving as a cognitive assessment tool. The paper, published in The Journal of Prevention of Alzheimer's Disease, details the full protocol for a novel AI-driven screening platform designed to bring Alzheimer's diagnostics int...

New Peer-Reviewed Study Using BrainCheck Identifies Four Distinct Cognitive Trajectories in Patients Hospitalized for COVID-19

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a cognitive workflow platform, today highlighted the publication of a peer-reviewed longitudinal study conducted at UTHealth Houston that used BrainCheck to track cognitive outcomes in patients hospitalized for COVID-19 over a 36-month period. The study, published in The Journal of Neuropsychiatry and Clinical Neurosciences, represents one of the largest and longest-running evaluations of cognitive outcomes following COVID-19 hospitali...

Dr. Stephen Bekanich Joins BrainCheck as Chief Medical Officer

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a digital platform for cognitive assessment and care, today announced that Stephen Bekanich, M.D., has joined the company as Chief Medical Officer. In this role, Dr. Bekanich will lead BrainCheck’s clinical strategy and help expand its value-based and collaborative care initiatives as the company continues to scale nationally. Dr. Bekanich brings decades of experience in geriatric medicine, palliative care, accountable care organizatio...
Back to Newsroom